[Duspatalin in functional disorders of the Oddi's sphincter in patients subjected cholecystectomy].
There was an examination of 20 patients who had cholecystectomy and have dysfunctional disorders of the Oddi's sphincter. All of the patients underwent the monotherapy with Mebeverine Retard in the dosage of 200 mg twice a day. The treatment efficiency was evaluated by the dynamics of clinical symptoms, results of the study of biochemical blood indices, data of the ultrasonic examination, and intragastric pH measurement. A positive dynamics was observed against the background of the preparation administration, and it became apparent from the disappearance or reduction of pains strength, dyspeptic manifestations, normalization or improvement of biochemical blood indices, and reduction of the common bile duct lumen width according to the ultrasonic examination data.
Il'chenko
A A
AA
Central Scientific Research Institute of Gastroenterology, Moscow.
Bystrovskaia
E V
EV
D000328:Adult; D000368:Aged; D002763:Cholecystectomy / Q000009:adverse effects; D002769:Cholelithiasis / Q000601:surgery*; D003137:Common Bile Duct Diseases / Q000188:drug therapy* / Q000209:etiology / Q000503:physiopathology; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D010276:Parasympatholytics / Q000627:therapeutic use*; D010627:Phenethylamines / Q000627:therapeutic use*; D009803:Sphincter of Oddi / Q000187:drug effects* / Q000503:physiopathology
D010276:Parasympatholytics; D010627:Phenethylamines; C005096:mebeverine